COVID-19 Provider Relief Funding – Use of Funds, Attestations, and Risk Analysis
28 April 2020
In the face of COVID-19, every day brings new information to the ever-changing frontier of the Health Care Industry. For this brief webinar, we covered the requirements for health care providers that have received federal grants from HHS through the Provider Relief Fund, including how the money can be expended, requirements for reporting, tax consequences, and interaction with other sources of funding. There was also time to ask questions during the presentation.
We also recently published a blog titled, “Understanding HHS’s Plans to Disperse Provider Relief Funds Authorized By The CARES Act,” which you can read by clicking here.
People
Related Insights
01 May 2024
Article
DOJ and FTC Raise Concerns about Overlapping Ownership in Public Utility Companies
On April 25, 2024, the U.S. Department of Justice Antitrust Division and the Federal Trade Commission filed a joint comment with the Federal Energy Regulatory Commission raising concerns about FERC’s blanket authorization policy, which, among other things, allows holding companies, including investment companies, to acquire noncontrolling ownership interests in public utility companies, subject to certain conditions.
22 May 2024
Events
May 2024 Midwest Cyber Security Alliance Meeting | Integrating Trending AI and CMMC Compliance Into Vendor Management
Join us on Wednesday, May 22, 2024, at the next Midwest Cyber Security Alliance meeting, where sponsor Sikich LLP, along with Foley attorneys Chanley Howell and Leighton Allen, will delve into the integration of two critical components — AI due diligence and Cybersecurity Maturity Model Certification (CMMC) compliance — to fortify vendor management practices.
16 May 2024
Events
Litigating Patent Claims at the ITC and How It Could Impact Your Company
The U.S. International Trade Commission is a fast-paced, high-stakes forum empowered by Section 337 of the U.S. Tariff Act to hear and resolve patent infringement complaints brought by companies against acts in the importation of products.